Bio-Rad Laboratories Class B
BIO.B
10 hedge funds and large institutions have $10.3M invested in Bio-Rad Laboratories Class B in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 6 → 10 (+4)
57% more capital invested
Capital invested by funds: $6.6M → $10.3M (+$3.73M)
0.13% more ownership
Funds ownership: 0.22% → 0.35% (+0.13%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$3.53M |
| 2 |
SF
Synovus Financial
Columbus,
Georgia
|
+$476K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$269K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$357K |
| 2 |
GAM
Gemmer Asset Management
Walnut Creek,
California
|
-$11.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $4.21M | – | – | – |
|
|
2
Royal London Asset Management
United Kingdom
| $3.43M | +$3.53M | +5,927 | New |
|
|
3
Renaissance Technologies
New York
| $1.33M | -$357K | -600 | -21% |
|
|
SF
4
Synovus Financial
Columbus,
Georgia
| $465K | +$476K | +801 | New |
|
5
Morgan Stanley
New York
| $394K | – | – | – |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $257K | +$269K | +452 | New |
|
|
GAM
7
Gemmer Asset Management
Walnut Creek,
California
| $159K | -$11.9K | -20 | -7% |
|
8
Wells Fargo
San Francisco,
California
| $32K | – | – | – |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $29K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $23K | +$23.8K | +40 | New |
|
BIO.B Hedge Fund Activity: Q1 2021 in Review
10 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2021, worth a combined $10.3M — up 57% from $6.6M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BIO.B positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Royal London Asset Management, opening a new position worth an estimated $3.53M. The largest seller was Renaissance Technologies, cutting an estimated $357K.
- 10 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2021, up from 6 in Q4 2020.
- Funds reported $10.3M of Bio-Rad Laboratories Class B stock for Q1 2021, up 57% quarter-over-quarter.
- 4 funds opened new Bio-Rad Laboratories Class B positions in Q1 2021 and 0 closed out, a net change of +4 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2021 was Royal London Asset Management, an estimated $3.53M added.
- The largest Bio-Rad Laboratories Class B seller in Q1 2021 was Renaissance Technologies, an estimated $357K sold.
Based on aggregated 13F filings for Q1 2021.